Slingshot members are tracking this event:
Having now demonstrated bioequivalence for its Rexista Oxycodone XR product, Intellipharmaceutics intends to file a New Drug Application within the next 6 months
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|IPCI||Community voting in process|
Slingshot Insights Explained
Jul 05, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Bioequivalence, Rexista Oxycodone Xr, Nda